<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19252736</article-id><article-id pub-id-type="pmc">2646837</article-id><article-id pub-id-type="publisher-id">08-PONE-RA-07034R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0004658</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry</subject><subject>Microbiology</subject><subject>Biotechnology/Bioengineering</subject></subj-group></article-categories><title-group><article-title>Structural Basis and Catalytic Mechanism for the Dual Functional Endo-&#x003b2;-N-Acetylglucosaminidase A</article-title><alt-title alt-title-type="running-head">Crystal Structure of Endo-A</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Yin</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Li</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shaw</surname><given-names>Neil</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>Jing Katherine</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Wenpeng</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xia</surname><given-names>Chengfeng</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Rongguang</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Joachimiak</surname><given-names>Andrzej</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Hou-Cheng</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Lai-Xi</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Zhi-Jie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Peng</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Graduate School of the Chinese Academy of Sciences, Beijing, China</addr-line></aff><aff id="aff3"><label>3</label><addr-line>National Glycoengineering Research Center and The State Key Laboratory of Microbial Technology, School of Life Sciences, Shandong University, Shandong, China</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Departments of Biochemistry and Chemistry, The Ohio State University, Columbus, Ohio, United States of America</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Structural Biology Center, Advanced Photon Source, Argonne National Laboratory, Illinois, United States of America</addr-line></aff><aff id="aff6"><label>6</label><addr-line>Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America</addr-line></aff><aff id="aff7"><label>7</label><addr-line>College of Pharmacy and The State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin, China</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Kobe</surname><given-names>Bostjan</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of Queensland, Australia</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>zjliu@ibp.ac.cn</email> (Z-JL); <email>pwang@sdu.edu.cn</email> (PW)</corresp><fn fn-type="con"><p>Conceived and designed the experiments: PW ZJL. Performed the experiments: JY LL JKS WZ CX RZ HCZ. Analyzed the data: JY LL NS YL JKS WZ CX RZ ZJL. Contributed reagents/materials/analysis tools: AJ LXW PW. Wrote the paper: JY LL NS ZJL.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>2</day><month>3</month><year>2009</year></pub-date><volume>4</volume><issue>3</issue><elocation-id>e4658</elocation-id><history><date date-type="received"><day>27</day><month>10</month><year>2008</year></date><date date-type="accepted"><day>7</day><month>1</month><year>2009</year></date></history><copyright-statement>Yin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2009</copyright-year><abstract><p>Endo-&#x003b2;-<italic>N</italic>-acetylglucosaminidases (ENGases) are dual specificity enzymes with an ability to catalyze hydrolysis and transglycosylation reactions. Recently, these enzymes have become the focus of intense research because of their potential for synthesis of glycopeptides. We have determined the 3D structures of an ENGase from <italic>Arthrobacter protophormiae</italic> (Endo-A) in 3 forms, one in native form, one in complex with Man<sub>3</sub>GlcNAc-thiazoline and another in complex with GlcNAc-Asn. The carbohydrate moiety sits above the TIM-barrel in a cleft region surrounded by aromatic residues. The conserved essential catalytic residues &#x02013; E173, N171 and Y205 are within hydrogen bonding distance of the substrate. W216 and W244 regulate access to the active site during transglycosylation by serving as &#x0201c;gate-keepers&#x0201d;. Interestingly, Y299F mutation resulted in a 3 fold increase in the transglycosylation activity. The structure provides insights into the catalytic mechanism of GH85 family of glycoside hydrolases at molecular level and could assist rational engineering of ENGases.</p></abstract><counts><page-count count="11"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Endo-&#x003b2;-<italic>N</italic>-acetylgucosaminidases (EC 3.2.1.96) (ENGases) are a class of enzymes that hydrolyze the glycosidic bond - GlcNAc &#x003b2;-1,4GlcNAc - present in <italic>N</italic>-linked sugar chains in glycoproteins and release the <italic>N</italic>-glycan moiety. These enzymes are key enzymes in the processing event of free oligosaccharides in the cytosol <xref ref-type="bibr" rid="pone.0004658-Suzuki1">&#x0005b;1&#x0005d;</xref>. ENGases are widely distributed in bacteria <xref ref-type="bibr" rid="pone.0004658-Takegawa1">&#x0005b;2&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004658-Fujita1">&#x0005b;4&#x0005d;</xref>, fungi <xref ref-type="bibr" rid="pone.0004658-Kadowaki1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004658-Kadowaki2">&#x0005b;6&#x0005d;</xref>, plants <xref ref-type="bibr" rid="pone.0004658-Li1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004658-Kimura1">&#x0005b;8&#x0005d;</xref> and animals <xref ref-type="bibr" rid="pone.0004658-Ito1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004658-Suzuki2">&#x0005b;10&#x0005d;</xref>. According to amino acid sequence similarity, the enzymes are classified into glycoside hydrolase families GH18 and GH85 <xref ref-type="bibr" rid="pone.0004658-Fan1">&#x0005b;11&#x0005d;</xref>. Besides hydrolysis, some ENGases of GH85 family possess transglycosylation activity, i.e., the ability to transfer the released oligosaccharide moiety to a suitable acceptor other than water. For example, Endo-A can transfer a high-mannose type oligosaccharide to monosaccharides such as <italic>N</italic>-acetylglucosamine (GlcNAc) and glucose to form a new oligosaccharide <xref ref-type="bibr" rid="pone.0004658-Takegawa1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004658-Fan1">&#x0005b;11&#x0005d;</xref>, whereas the ENGase from <italic>Mucor hiemalis</italic> (Endo-M), exhibits significant transglycosylation activity towards complex type oligosaccharides <xref ref-type="bibr" rid="pone.0004658-Yamamoto1">&#x0005b;12&#x0005d;</xref>. When the acceptor is a pre-assembled GlcNAc-containing peptide or protein, Endo-A and Endo-M are able to transfer an intact oligosaccharide to the acceptor to form a new glycopeptide or glycoprotein in a single step, making it a highly convergent chemoenzymatic approach <xref ref-type="bibr" rid="pone.0004658-Wang1">&#x0005b;13&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004658-Wang3">&#x0005b;15&#x0005d;</xref>. However, ENGases are inherently a class of hydrolases. The transglycosylation activities in general are relatively low in comparison with their hydrolytic activity, particularly when natural <italic>N</italic>-glycan or natural glycopeptide is used as the donor substrate. Moreover, product hydrolysis is a major issue for this chemoenzymatic approach, as the product thus formed would turn out to be the substrate of the enzyme. Recently, exploration of synthetic sugar oxazolines (<xref ref-type="fig" rid="pone-0004658-g001">Figure 1A</xref>) <xref ref-type="bibr" rid="pone.0004658-Li2">&#x0005b;16&#x0005d;</xref>, the mimics of the presumed enzymatic reaction intermediate, as the donor substrates has not only broadened the availability of donor substrates, but also significantly enhanced the overall efficiency of the chemoenzymatic synthesis <xref ref-type="bibr" rid="pone.0004658-Umekawa1">&#x0005b;17&#x0005d;</xref>. A number of homogeneous natural and unnatural <italic>N</italic>-glycopeptides and glycoproteins were synthesized by this chemoenzymatic approach (<xref ref-type="fig" rid="pone-0004658-g001">Figure 1B</xref>) <xref ref-type="bibr" rid="pone.0004658-Li2">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004658-Ochiai1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004658-Wei1">&#x0005b;19&#x0005d;</xref>. It was shown that the slightly modified <italic>N</italic>-glycan oxazoline could serve as a substrate for transglycosylation, but the resulting <italic>N</italic>-glycopeptide or <italic>N</italic>-glycoprotein, with a truncated or structurally modified <italic>N</italic>-glycan would become resistant to enzymatic hydrolysis due to the slight modification. Nevertheless, product hydrolysis is still a problem when this chemoenzymatic approach is applied to the synthesis of glycoproteins carrying natural <italic>N</italic>-glycans, as the ENGases can rapidly hydrolyze the natural <italic>N</italic>-glycans.</p><fig id="pone-0004658-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004658.g001</object-id><label>Figure 1</label><caption><title>Synthesis of glycopeptides using oligosaccharide oxazolines as sugar donors.</title><p>(A) Mimic of oxazoline ion intermediate, Man<sub>3</sub>GlcNAc-oxazoline. (B) Endo-A catalyzed glycopeptide synthesis by using Man<sub>3</sub>GlcNAc-oxazoline. (C) An Endo-A inhibitor, Man<sub>3</sub>GlcNAc-thiazoline.</p></caption><graphic xlink:href="pone.0004658.g001"/></fig><p>One solution to this problem is to create a glycosynthase that lacks hydrolytic activity but retains transglycosylation activity <xref ref-type="bibr" rid="pone.0004658-Mackenzie1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004658-Perugino1">&#x0005b;21&#x0005d;</xref>. In case of a retaining glycosidase, a glycosynthase might be generated by mutating the catalytic nucleophile to a non-nucleophilic residue. The resulting mutant enzyme would lack hydrolytic activity but might still accept an activated glycosyl donor such as glycosyl fluoride with an opposite anomeric configuration for transglycosylation <xref ref-type="bibr" rid="pone.0004658-Perugino1">&#x0005b;21&#x0005d;</xref>. The routinely employed nucleophile substitution strategy that converts a glycoside hydrolase to a glycosynthase cannot be applied to ENGases because catalysis in ENGases proceeds via a substrate-assisted retaining mechanism <xref ref-type="bibr" rid="pone.0004658-Li2">&#x0005b;16&#x0005d;</xref>. Recent mutagenesis and screening of Endo-M has created some promising mutants that showed glycosynthase activity, that is, they could accept sugar oxazoline corresponding to natural <italic>N</italic>-glycan as substrate for transglycosylation, but lacked the activity to hydrolyze the product <xref ref-type="bibr" rid="pone.0004658-Umekawa1">&#x0005b;17&#x0005d;</xref>. But, unfortunately, the absence of a representative structure for GH85 family of enzymes has become a major bottleneck for rationally engineering ENGases with enhanced transglycosylation activities devoid of hydrolytic activity.</p><p>In order to delineate the structural basis for the hydrolysis and transglycosylation activities of Endo-A, we have determined the 3D structures of Endo-A in native form and in complex with Man<sub>3</sub>GlcNAc-thiazoline (<xref ref-type="fig" rid="pone-0004658-g001">Fig 1C</xref>) and GlcNAc-Asn. Man<sub>3</sub>GlcNAc-thiazoline is an oxazoline mimic in which the anomeric oxygen at the reducing end was replaced with a sulfur atom (<xref ref-type="fig" rid="pone-0004658-g001">Fig 1C</xref>). The Man<sub>3</sub>GlcNAc-thiazoline could be regarded as a transition state mimic and was resistant to Endo-A hydrolysis. It was shown to be an inhibitor for Endo-A <xref ref-type="bibr" rid="pone.0004658-Li3">&#x0005b;22&#x0005d;</xref>. Using the structure of binary complexes as a guide, we have successfully engineered the transglycosylation activity of Endo-A. Further, the structural basis and catalytic mechanism for this dual functional Endo-A is discussed.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Overall structure of Endo-A</title><p>Endo-A from <italic>Arthrobacter protophormiae</italic> is modular in architecture with three distinct domains (<xref ref-type="fig" rid="pone-0004658-g002">Figure 2A</xref>). Sequence analysis of Endo-A carried out previously had failed to identify domains 2 and 3 of the enzyme. Domain 1 (<xref ref-type="fig" rid="pone-0004658-g002">Figure 2B</xref>), with residues 2&#x02013;350 being identified, is the largest and displays a typical (&#x003b2;/&#x003b1;)<sub>8</sub> TIM barrel fold, which has been observed for proteins belonging to family GH18 and GH20 of the glycoside hydrolases. The overall architecture of the domain 1 is similar to that observed in the structure of Endo-F3 <xref ref-type="bibr" rid="pone.0004658-Waddling1">&#x0005b;23&#x0005d;</xref>. Endo-A has been postulated to carry out substrate hydrolysis and transglycosylation activities using this domain. In addition, the structure of Endo-A reveals two smaller domains, primarily made up of &#x003b2; sheets. The secondary structural elements of these two domains are interdigitated (<xref ref-type="fig" rid="pone-0004658-g002">Figure 2A, 2B</xref>). MSD Fold search (<ext-link ext-link-type="uri" xlink:href="http:www.ebi.ac.uk/msd-srv/ssm">http:www.ebi.ac.uk/msd-srv/ssm</ext-link>) for structural homologues of domain 2 and 3 revealed that domain 2 of Endo-A shows similarity to a CBM (carbohydrate binding module, supplementary <xref ref-type="supplementary-material" rid="pone.0004658.s002">Figure S1</xref>, supplementary <xref ref-type="supplementary-material" rid="pone.0004658.s001">Text S1</xref>), while the secondary structural elements of domain 3 are similar to Fn3 (fibronectin type III domain, supplementary <xref ref-type="supplementary-material" rid="pone.0004658.s003">Figure S2</xref>, supplementary <xref ref-type="supplementary-material" rid="pone.0004658.s001">Text S1</xref>).</p><fig id="pone-0004658-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004658.g002</object-id><label>Figure 2</label><caption><title>Structure of Endo-A.</title><p>(A) Diagrammatic representation of Endo-A. Amino acids 1&#x02013;350 make up Domain 1 (blue), segments 351&#x02013;362 and 387&#x02013;524 make up Domain 2 (orange), while segments 363&#x02013;386 and 525&#x02013;611 make up Domain 3 (red). (B) Stereo image of Endo-A. Man<sub>3</sub>GlcNAc-thiazoline moiety is shown as sticks. (C) A surface electrostatic potential representation of Endo-A showing the Man<sub>3</sub>GlcNAc-thiazoline moiety sitting inside the active site cleft.</p></caption><graphic xlink:href="pone.0004658.g002"/></fig><p>In order to determine the structural basis for the binding of the substrate and molecular mechanism for the hydrolysis and transglycosylation activities, we solved the structures of Endo-A in complex with an oxazoline ion intermediate mimic &#x02013; Man<sub>3</sub>GlcNAc-thiazoline <xref ref-type="bibr" rid="pone.0004658-Li3">&#x0005b;22&#x0005d;</xref> and an acceptor substrate &#x02013; GlcNAc-Asn. The overall structures of the Endo-A in complex with Man<sub>3</sub>GlcNAc-thiazoline and Endo-A in complex with GlcNAc-Asn are identical to that of the free protein. When compared to the structure of carbohydrate bound Endo-F3, differences are in the loop region surrounding the active site indicating different substrate specificities for the enzymes. Superimposition studies show that the catalytic amino acids occupy similar positions in Endo-A and Endo-F3 structures. The carbohydrate moiety is sitting in a negatively charged cleft region above the &#x003b2;-barrel (<xref ref-type="fig" rid="pone-0004658-g002">Figure 2C</xref>). Electron density for the ligands was of good quality and most of the backbone for the GlcNAc-Asn and Man<sub>3</sub>GlcNAc-thiazoline could be traced (<xref ref-type="fig" rid="pone-0004658-g003">Figure 3A, 3B</xref>).</p><fig id="pone-0004658-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004658.g003</object-id><label>Figure 3</label><caption><title>Stereo images of Endo-A in complex with GlcNAc-Asn (panel A) and Man<sub>3</sub>GlcNAc-thiazoline (panel B).</title><p>The ligand omitted |Fo|-|Fc| &#x003b1;<sub>calc</sub> electron density map, calculated using a 3.5 &#x000c5; resolution data set, shown in blue, was contoured at 2.5&#x003c3;.</p></caption><graphic xlink:href="pone.0004658.g003"/></fig></sec><sec id="s2b"><title>Active site of Endo-A</title><p>The carbohydrate moiety is sitting above the &#x003b2;-barrel and the critical catalytic residues &#x02013; N171, E173 and Y205 <xref ref-type="bibr" rid="pone.0004658-Umekawa1">&#x0005b;17&#x0005d;</xref>&#x02013; are hydrogen bonded to GlcNAc-Asn. A number of other residues &#x02013; W93, F125, W216, F243, W244 and Y299 are interacting with GlcNAc-Asn (<xref ref-type="fig" rid="pone-0004658-g004">Figure 4A</xref>). Two loops, comprising of residues 205&#x02013;224 and 242&#x02013;248 respectively (shown in red, <xref ref-type="fig" rid="pone-0004658-g004">Figure 4A</xref>), are regulating access of the active site to the acceptor. More specifically, W216 and W244, facing each other, are speculated to serve as gate-keepers for the active site during transglycosylation (<xref ref-type="fig" rid="pone-0004658-g004">Figure 4B</xref>). In the structures of the free Endo-A and Endo-A bound to Man<sub>3</sub>GlcNAc-thiazoline (<xref ref-type="fig" rid="pone-0004658-g004">Figure 4C</xref>), the side chain of W244 is perpendicular to W216 and introduces a steric block at the entrance of the active site. During transglycosylation, the side chain of W244 moves away from the &#x003b2; barrel, becoming parallel to W216 and makes way for the acceptor to enter the active site (<xref ref-type="fig" rid="pone-0004658-g004">Figure 4B</xref>). Mutagenesis studies reported previously have indicated the importance of W216 and W244 in transglycosylation. When W216 was mutated to an arginine, Endo-A lost its ability to carry out transglycosylation <xref ref-type="bibr" rid="pone.0004658-Fujita2">&#x0005b;24&#x0005d;</xref>. Similarly, W251N mutation in Endo-M (equivalent to W244 in Endo-A) reduced the transglycosylation yields dramatically<xref ref-type="bibr" rid="pone.0004658-Umekawa1">&#x0005b;17&#x0005d;</xref>. The minimum distance between the two tryptophans is 6.3 &#x000c5; (<xref ref-type="fig" rid="pone-0004658-g004">Figure 4B</xref>), which is sufficient to allow the passage of an acceptor. Such features are not seen in the structures of Endo-F and Endo-H, both of which have the ability to carry out hydrolysis but lack transglycosylation activities <xref ref-type="bibr" rid="pone.0004658-Hauser1">&#x0005b;25&#x0005d;</xref>. W216 and W244 probably play a critical role in recognition and docking of the incoming acceptor.</p><fig id="pone-0004658-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004658.g004</object-id><label>Figure 4</label><caption><title>Active site of Endo-A.</title><p>(A) N171, E173 and Y299 are critical for catalysis. Amino acids surrounding the carbohydrate moiety are shown as sticks. The distances are shown in dashed lines. The GlcNAc-Asn moiety is shown as sticks. (B) W216 and W244 are &#x0201c;gate-keeping&#x0201d; the active site by sterically regulating access to the active site by the acceptor. The side chain of W244 moves during transglycosylation; the distance between the two Trp is much wider and allows passage of an acceptor into the active site. Trp and GlcNAc-Asn are shown as sticks. (C) The gate is &#x0201c;closed&#x0201d; in the structure of free protein (not shown) and Man<sub>3</sub>GlcNAc-thiazoline bound Endo-A (shown as sticks).</p></caption><graphic xlink:href="pone.0004658.g004"/></fig><p>Endo-A catalyses hydrolysis and transglycosylation via a substrate-assisted mechanism, in which the C2 acetamido group mounts a nucleophilic attack at the anomeric carbon resulting in the formation of an oxazoline ion intermediate. This mechanism has been substantiated in part by the observation that the mimics of the oxazoline ion intermediate, such as Man<sub>3</sub>GlcNAc-thiazoline, are potent inhibitors of Endo-A <xref ref-type="bibr" rid="pone.0004658-Li3">&#x0005b;22&#x0005d;</xref>. In order to obtain information about the transition state, we solved the crystal structure of Endo-A in complex with Man<sub>3</sub>GlcNAc-thiazoline (<xref ref-type="fig" rid="pone-0004658-g003">Figure 3B</xref>). While the thiazoline part of the carbohydrate moiety is buried deep inside a hydrophobic pocket formed by W93, F125, Y131, F169, Y205, F240, F243 and Y299, the mannose rings reside on the surface. As expected, the nitrogen atom of the thiazoline is hydrogen bonded to the side chain oxygen atom of N171 (supplementary <xref ref-type="supplementary-material" rid="pone.0004658.s004">Figure S3</xref>). N171 probably orients the acetamido group for a nucleophilic attack and also stabilizes the transition states.</p></sec><sec id="s2c"><title>Site-directed mutagenesis of critical residues</title><p>In order to probe the role of residues surrounding the carbohydrate moiety in the function of Endo-A, we carried out mutagenesis and performed hydrolysis and transglycosylation assays using the mutants. Using the structures of the binary complexes of Endo-A and results of previous mutagenesis studies of Endo-M <xref ref-type="bibr" rid="pone.0004658-Umekawa1">&#x0005b;17&#x0005d;</xref> as a guide, residues N171, Y205, and Y299 were selected for mutagenesis in order to engineer an Endo-A with diminished hydrolysis activity and enhanced transglycosylation activity. N171A, Y205F and Y299F mutants were expressed as soluble proteins and purified to homogeneity. The hydrolysis activity was detected using ribonuclease B as the substrate <xref ref-type="bibr" rid="pone.0004658-Takegawa1">&#x0005b;2&#x0005d;</xref> and the transglycosylation assay was performed according to the chitinase-coupled assay method <xref ref-type="bibr" rid="pone.0004658-Umekawa1">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004658-Hauser1">&#x0005b;25&#x0005d;</xref>. In the chitinase-coupled assay, the transglycosylation product, Man<sub>9</sub>GlcNAc<sub>2</sub>-4-methylumbelliferyl was further hydrolyzed to release a fluorophore, 4-methylumbelliferone (4MU). The fluorescence signal can be correlated to the formation of transglycosylation product. As expected, the mutation N171A completely abolished all enzymatic activity of Endo-A (<xref ref-type="table" rid="pone-0004658-t001">Table 1</xref>). These results are similar to those previously reported for a corresponding residue, N175, in Endo-M, indicating an asparagine at this position is critical for the activity <xref ref-type="bibr" rid="pone.0004658-Umekawa1">&#x0005b;17&#x0005d;</xref>. In the structure of Endo-A in complex with Man<sub>3</sub>GlcNAc-thiazoline, N171 is hydrogen bonded to the thiazoline nitrogen - mimicking the ability of the asparagine to orient the acetamido group for a nucleophilic attack on the anomeric carbon (supplementary <xref ref-type="supplementary-material" rid="pone.0004658.s004">Figure S3</xref>). Mutant Y205F exhibited reduced hydrolysis activity with an increase in transglycosylation yields (<xref ref-type="table" rid="pone-0004658-t001">Table 1</xref>, <xref ref-type="fig" rid="pone-0004658-g005">Figure 5</xref>). Although the transglycosylation activity was similar to that of the wild type Endo-A in 30 minutes, the yield of the transglycosylation product for Y205F is twice as that of the wild type Endo-A after 120 minutes under similar conditions of the assay (<xref ref-type="fig" rid="pone-0004658-g005">Figure 5</xref>). A similar mutation in Endo-M (Y217F) was shown to decrease the hydrolysis activity and increase the transglycosylation activity. Analysis of the structure of Endo-A reveals that the Y205F mutation probably results in loss of a potential nucleophile, H<sub>2</sub>O846, which is hydrogen bonded to the hydroxyl oxygen of Y205. Interestingly, another mutation of Endo-A involving a tyrosine, Y299F, showed 3 times higher transglycosylation activity than the wild type Endo-A, while the hydrolysis activity remained unchanged (<xref ref-type="table" rid="pone-0004658-t001">Table 1</xref>). The hydroxyl group of Y299 is forming a hydrogen bond with the oxygen atom of the C2 acetamido group of GlcNAc-Asn (supplementary <xref ref-type="supplementary-material" rid="pone.0004658.s005">Figure S4</xref>). A loss of the hydroxyl group in the Y299F mutation probably helps release the product faster resulting in an increase in the transglycosylation rate. The transglycosylation product yield for Y299F was 3 times of that of the wild type Endo-A (<xref ref-type="fig" rid="pone-0004658-g005">Figure 5</xref>).</p><fig id="pone-0004658-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004658.g005</object-id><label>Figure 5</label><caption><title>Transglycosylation activity of Endo-A mutants.</title><p>Time course of transglycosylation reaction of wildtype Endo-A (squares) and the three mutants, N171A (circles), Y205F (triangles), and Y299F (diamonds). The reactions were carried out using a chitinase-coupled assay, in which Man<sub>9</sub>GlcNAc<sub>2</sub>Asn-Fmoc was used as the donor substrate and 4MU-GlcNAc as the acceptor, 0.25 &#x000b5;g of each enzyme was used in a 50 &#x000b5;l system.</p></caption><graphic xlink:href="pone.0004658.g005"/></fig><table-wrap id="pone-0004658-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004658.t001</object-id><label>Table 1</label><caption><title>Hydrolysis and transglycosylation activities of Endo-A mutants.</title></caption><graphic id="pone-0004658-t001-1" xlink:href="pone.0004658.t001"/><table frame="hsides" rules="groups" alternate-form-of="pone-0004658-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Mutant</td><td align="left" rowspan="1" colspan="1">Specific hydrolysis activity<xref ref-type="table-fn" rid="nt101">a</xref></td><td align="left" rowspan="1" colspan="1">Percentage of specific hydrolysis activity</td><td align="left" rowspan="1" colspan="1">Specific transglycosylation activity<xref ref-type="table-fn" rid="nt101">a</xref></td><td align="left" rowspan="1" colspan="1">Percentage of specific transglycosylation activity</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">mg min<sup>&#x02212;1</sup> mg<sup>&#x02212;1</sup></td><td align="left" rowspan="1" colspan="1">&#x00025;</td><td align="left" rowspan="1" colspan="1">&#x000b5;mol min<sup>&#x02212;1</sup> mg<sup>&#x02212;1</sup></td><td align="left" rowspan="1" colspan="1">&#x00025;</td></tr><tr><td align="left" rowspan="1" colspan="1">Wildtype</td><td align="left" rowspan="1" colspan="1">21.1</td><td align="left" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">1.72</td><td align="left" rowspan="1" colspan="1">100</td></tr><tr><td align="left" rowspan="1" colspan="1">N171A</td><td align="left" rowspan="1" colspan="1">ND<xref ref-type="table-fn" rid="nt102">b</xref></td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">0.53</td></tr><tr><td align="left" rowspan="1" colspan="1">Y205F</td><td align="left" rowspan="1" colspan="1">9.39</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">1.61</td><td align="left" rowspan="1" colspan="1">94</td></tr><tr><td align="left" rowspan="1" colspan="1">Y299F</td><td align="left" rowspan="1" colspan="1">21.4</td><td align="left" rowspan="1" colspan="1">101</td><td align="left" rowspan="1" colspan="1">5.11</td><td align="left" rowspan="1" colspan="1">297</td></tr></tbody></table><table-wrap-foot><fn id="nt101"><label>a</label><p>The hydrolysis activity was determined using Ribonuclease B as the substrate, the transglycosylation activity was measured using a chitinase-coupled assay, in which Man<sub>9</sub>GlcNAc<sub>2</sub>Asn-Fmoc was used as the donor substrate and 4MU-GlcNAc as the acceptor.</p></fn><fn id="nt102"><label>b</label><p>ND, not detected.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s3"><title>Discussion</title><sec id="s3a"><title>Mechanism of hydrolysis and transglycosylation</title><p>Hydrolysis in Endo-A is driven by the 2-acetamido component, which acts as a nucleophile in a substrate assisted hydrolysis mechanism. Analysis of the structure of the binary complex of Endo-A with Man<sub>3</sub>GlcNAc-thiazoline reveals that E173 is well positioned to carry out the protonation of the anomeric carbon (<xref ref-type="fig" rid="pone-0004658-g004">Figure 4A</xref>, <xref ref-type="fig" rid="pone-0004658-g006">6</xref>). This critical glutamic acid is highly conserved and is observed in all members of the GH85 family of hydrolases. The side chain oxygen of N171 is forming a hydrogen bond at a distance of 2.6 &#x000c5; with the nitrogen of the C2-acetamido group of the substrate. This is critical for maintaining the correct orientation of the substrate and may help stabilize the oxazoline ion intermediate during substrate assisted catalysis. The oxazoline ion intermediate is subject to further hydrolysis by a water molecule likely to be activated by the hydroxyl oxygen of Y205 or transferred to an acceptor substrate (<xref ref-type="fig" rid="pone-0004658-g006">Figure 6</xref>). In the structure of ligand-free Endo-A, H<sub>2</sub>O846 is interacting with Y205 and could fulfill the role of a potential nucleophile. In addition, the hydroxyl oxygen of Y205 is in close proximity of the oxygen atom of the C2-acetoamido group. Y217A mutation in Endo-M (equivalent to Y205 in Endo-A) was shown to severely compromise the enzymatic activity previously <xref ref-type="bibr" rid="pone.0004658-Umekawa1">&#x0005b;17&#x0005d;</xref>. The oxazoline ion intermediate is alternatively synthesized via a substrate assisted catalytic mechanism. N171 orients the acetamido group at C-2 position such that it can mount a nucleophilic attack at the anomeric carbon (<xref ref-type="fig" rid="pone-0004658-g006">Figure 6</xref>, supplementary <xref ref-type="supplementary-material" rid="pone.0004658.s004">Figure S3</xref>). In the structure of Endo-A complexed with GlcNAc-Asn, the carboxyl oxygen of E173 is forming a 2.8 &#x000c5; hydrogen bond with the O4 hydroxyl oxygen of the pyranoside ring of GlcNAc-Asn (<xref ref-type="fig" rid="pone-0004658-g004">Figure 4A</xref>). This interaction activates the acceptor, which can now bind the oxazoline ion intermediate. The overall configuration of the newly synthesized &#x003b2;, 1&#x02013;4 linkage is the same as that of the one that was hydrolyzed from the donor.</p><fig id="pone-0004658-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004658.g006</object-id><label>Figure 6</label><caption><title>Mechanism of Endo-A mediated catalysis.</title><p>(A) Substrate surrounded by critical amino acids - N171, E173 and Y205. The nucleophilic oxygen (O) is marked with &#x0002a;. (B) Intramolecular nucleophilic attack. (C) Formation of an oxazoline ion intermediate. (D) Second nucleophilic attack on the intermediate. (E) Synthesis of a new glycosidic bond. R' could be a GlcNAc molecule of an acceptor during transglycosylation.</p></caption><graphic xlink:href="pone.0004658.g006"/></fig></sec><sec id="s3b"><title>Engineering ENGases</title><p>The Y205F mutation of Endo-A carried out in this study resulted in a decrease up to 56&#x00025; of the hydrolysis activity (<xref ref-type="table" rid="pone-0004658-t001">Table 1</xref>). Although the transglycosylation activity did not change significantly when compared to the wild type Endo-A, the Y205F mutant of Endo-A could accumulate 2.5 times more transglycosylation product. Mutating Y217 in Endo-M (equivalent to Y205 in Endo-A) to any other amino acid inactivated the enzyme <xref ref-type="bibr" rid="pone.0004658-Umekawa1">&#x0005b;17&#x0005d;</xref>. Therefore, a phenyl ring is critical at this position. Interestingly, another mutant of Endo-A - Y299F - exhibited 3 fold more transglycosylation activity when compared to the wild type Endo-A (<xref ref-type="table" rid="pone-0004658-t001">Table 1</xref>). Analysis of the structure of GlcNAc-Asn bound Endo-A shows Y299 is hydrogen-bonded to the GlcNAc pyranose ring (supplementary <xref ref-type="supplementary-material" rid="pone.0004658.s005">Figure S4</xref>). A loss of the hydroxyl group, possibly disrupts this hydrogen bond and results in a much faster release of the product when compared to the wild type Endo-A. Thus, mutations that create a more hydrophobic environment facilitate the binding of the sugar moiety and promote the transglycosylation and/or the exclusion of H<sub>2</sub>O resulting in lower hydrolysis activity. Such mutations could be used to engineer ENGases with enhanced transglycosylation activity.</p><p>Product hydrolysis is a major issue during the synthesis of glycopeptides and glycoproteins, which makes the overall transglycosylation yield low. Perhaps, the ideal solution to address this problem is to develop glycosynthase-like ENGases. However, since ENGases follow a substrate assisted retaining type of mechanism <xref ref-type="bibr" rid="pone.0004658-Li2">&#x0005b;16&#x0005d;</xref> in which the second acidic amino acid that acts as a nucleophile does not participate in the catalysis, it makes the task of engineering the enzyme more difficult. The structure of Endo-A in complex with Man<sub>3</sub>GlcNAc-thiazoline reveals that N171 may be the essential residue that facilitates the intramolecular attack on GlcNAc during substrate assisted hydrolysis to form the 1,2-oxazoline ion intermediate (supplementary <xref ref-type="supplementary-material" rid="pone.0004658.s004">Figure S3</xref>). Such an intramolecular attack can be avoided by mutating N171 to a non-nucleophilic residue and would provide an opportunity to develop glycosynthase-like ENGases. In this study, N171A mutation of Endo-A abolished hydrolysis activity. Such an enzyme devoid of hydrolytic activity is well suited for carrying out transglycosylation using sugar oxazolines as donors. In a previous study, Endo-M N175A mutant exhibited transglycosylation activity (though the rate was much lower than the wild-type) without detectable hydrolytic activity when sugar oxazoline was used as a substrate <xref ref-type="bibr" rid="pone.0004658-Umekawa1">&#x0005b;17&#x0005d;</xref>.</p><p>In summary, we have determined the crystal structure of Endo-A, the first representative structure for members of the GH85 family of hydrolases. Insights into the structural basis and catalytic mechanism for the transglycosylation function have been gained by solving the structure in complex with an inhibitor and an &#x0201c;acceptor&#x0201d;. Y299F mutant exhibited 3 folds transglycosylation activity. The results of this study will assist rational engineering of ENGases.</p></sec></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Protein expression and purification</title><p>The 1863-base pair DNA fragment coding the 70 kDa Endo-A from <italic>Arthrobacter protophormiae</italic> was amplified from pGEX-2T/EndoA plasmid by using forward primer: <named-content content-type="gene">5&#x02032;-TAT<italic>CATATG</italic>TCTACGTACAACGGCCCGCTGT-3&#x02032;</named-content><italic> and reverse primer: <named-content content-type="gene">5&#x02032;-GAT<italic>GGATCCC</italic>TAAAACGAGCCGCTTTTTATGTCG-3&#x02032;</named-content></italic> containing restriction sites <italic>Nde</italic>I and <italic>BamH</italic>I, respectively. The resulting DNA fragment was ligated into vector pET15b (Novagen) and transformed into <italic>E. coli</italic> BL21(DE3) cells. The cells were cultured in LB medium containing ampicillin (100 &#x000b5;g/ml) at 37&#x000b0;C till OD<sub>600 nm</sub> reached 0.8. The culture was then induced with 0.2 mM IPTG for 20 h at 16&#x000b0;C. Cells were harvested by centrifugation and lysed by sonication in PBS (137 mM NaCl, 2.7 mM KCl, 50 mM Na<sub>2</sub>HPO<sub>4</sub>, 10 mM KH<sub>2</sub>PO<sub>4</sub>, pH 7.4) containing 0.2 mM PMSF. The lysate was clarified by centrifugation (30,000&#x000d7; g) for 30 min at 4&#x000b0;C. The supernatant was applied to Ni-NTA resin gravity column (Qiagen) that had been previously equilibrated with PBS. The column was first washed with 100 ml PBS followed by washing with 100 ml PBS containing 10 mM imidazole, and finally eluted with PBS containing 500 mM imidazole. After buffer exchange, His-tag was cleaved by thrombin treatment. Uncleaved protein was removed by Ni-affinity chromatography. Endo-A was further purified using Hitrap Q FF ion-exchange chromatography column (Amersham) equilibrated with buffer A (20 mM Tris-HCl, pH 8.0). After rigorous washing with buffer A, bound Endo-A was eluted using a linear gradient of 0 to 1 M NaCl in buffer A. Fractions containing the protein were pooled, concentrated and loaded on Superdex G200 size exclusion chromatography column (Amersham) equilibrated with 20 mM Tris-HCl, pH 8.0, and 200 mM NaCl. Fractions containing the protein were pooled and concentrated to 15 mg/ml before setting up crystallization trials. Se-Met labeled and methylated Endo-A <xref ref-type="bibr" rid="pone.0004658-Shaw1">&#x0005b;26&#x0005d;</xref> were purified using the same procedure.</p></sec><sec id="s4b"><title>Crystallization and data collection</title><p>Crystallization screening was carried out using commercially available sparse matrix screens - Wizard I, II and III (Molecular Dimensions). Trials for native and methylated protein were set up in 2 &#x000b5;l hanging drops containing equal amounts of protein and mother liquor equilibrated over 300 &#x000b5;l of reservoir solution. After 3 days of incubation at 16&#x000b0;C, the native and methylated protein crystallized in a mother-liquor solution containing 80 mM cacodylate, pH 6.5, 14&#x00025; (w/v) PEG 8000, 160 mM calcium acetate and 20&#x00025; (v/v) glycerol. After optimization of the initial crystallization condition, crystals for data collection were grown using 100 mM HEPES (pH 7.2) or 100 mM sodium acetate (pH 4.4), 14&#x00025; (w/v) PEG 8000, 160 mM calcium acetate and 20&#x00025; (v/v) glycerol. The crystals used for Se-SAD data collection were grown under similar conditions and appeared in one week. Endo-A crystals were soaked with Man<sub>3</sub>GlcNAc-thiazoline or GlcNAc-Asn at 16&#x000b0;C for 2 h before collecting data. A pinch of the substrate powder was directly added to the crystallization drop for soaking experiments. Crystals of the 70 kDa Endo-A belonged to P1 space group with four molecules of the protein in the asymmetric unit. The calculated Matthews coefficient was 2.34 &#x000c5;<sup>3</sup>/Dalton with a solvent content of 47&#x00025;.</p><p>Crystals were flash frozen in liquid nitrogen prior to data collection. Data sets for the methylated Endo-A native crystals were collected using a Rigaku FRE CuK&#x003b1; rotating anode X-ray source and RAXIS-IV<sup>&#x0002b;&#x0002b;</sup> detector. Although the crystals of methylated Endo-A diffracted well beyond 2.0 &#x000c5; resolution, due to the limitation of the unit cell parameters and the size of the X-ray beam and detector, the data sets were collected to 2.0 &#x000c5; resolution only. The data sets for crystals of non-methylated native Endo-A, selenomethionine labeled Endo-A and the two different complexes of Endo-A were collected at Se's peak wavelength (0.9794 &#x000c5;) using a Quantum-315 CCD area detector at beamline 19-ID and CCDSBC2 detector at 19-BM, Advanced Photon Source, Argonne National Laboratory. All data sets were collected at cryogenic temperature. The data were indexed, integrated and scaled using HKL2000 <xref ref-type="bibr" rid="pone.0004658-Otwinowski1">&#x0005b;27&#x0005d;</xref>. The crystals for methylated protein, selenomethionine derivatized and non-methylated native crystals diffracted X-rays to 2.0 &#x000c5;, 2.9 &#x000c5; and 2.3 &#x000c5; resolution respectively. The crystals of Endo-A in complex with Man<sub>3</sub>GlcNAc-thiazoline and in complex with GlcNAc-Asn diffracted X-rays to 2.5 &#x000c5; and 3.5 &#x000c5; resolution respectively. Details of data collection statistics are listed in <xref ref-type="table" rid="pone-0004658-t002">Table 2</xref>.</p><table-wrap id="pone-0004658-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004658.t002</object-id><label>Table 2</label><caption><title>Data collection and refinement statistics.</title></caption><graphic id="pone-0004658-t002-2" xlink:href="pone.0004658.t002"/><table frame="hsides" rules="groups" alternate-form-of="pone-0004658-t002-2"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Dataset</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">5</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Derivatization</td><td align="left" rowspan="1" colspan="1">Methylated</td><td align="left" rowspan="1" colspan="1">Se-Met</td><td align="left" rowspan="1" colspan="1">Non-methylated native</td><td align="left" rowspan="1" colspan="1">Endo-A with Man<sub>3</sub>GlcNAc-thiazoline</td><td align="left" rowspan="1" colspan="1">Endo-A with GlcNAc-Asn</td></tr><tr><td align="left" rowspan="1" colspan="1">X-ray Source</td><td align="left" rowspan="1" colspan="1">FRE&#x0002b; SuperBright&#x02122;</td><td align="left" rowspan="1" colspan="1">Advanced Photon Source</td><td align="left" rowspan="1" colspan="1">Advanced Photon Source</td><td align="left" rowspan="1" colspan="1">Advanced Photon Source</td><td align="left" rowspan="1" colspan="1">Advanced Photon Source</td></tr><tr><td align="left" rowspan="1" colspan="1">Detector</td><td align="left" rowspan="1" colspan="1">R-AXIS IV<sup>&#x0002b;&#x0002b;</sup></td><td align="left" rowspan="1" colspan="1">Quantum 315</td><td align="left" rowspan="1" colspan="1">Quantum 315</td><td align="left" rowspan="1" colspan="1">CCDSBC2</td><td align="left" rowspan="1" colspan="1">CCDSBC2</td></tr><tr><td align="left" rowspan="1" colspan="1">Crystal-to-detector distance (mm)</td><td align="left" rowspan="1" colspan="1">200</td><td align="left" rowspan="1" colspan="1">350</td><td align="left" rowspan="1" colspan="1">350</td><td align="left" rowspan="1" colspan="1">250</td><td align="left" rowspan="1" colspan="1">320</td></tr><tr><td align="left" rowspan="1" colspan="1">Wavelength (&#x000c5;)</td><td align="left" rowspan="1" colspan="1">1.54</td><td align="left" rowspan="1" colspan="1">0.9794</td><td align="left" rowspan="1" colspan="1">0.9794</td><td align="left" rowspan="1" colspan="1">0.9794</td><td align="left" rowspan="1" colspan="1">0.9794</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of images</td><td align="left" rowspan="1" colspan="1">360</td><td align="left" rowspan="1" colspan="1">480</td><td align="left" rowspan="1" colspan="1">360</td><td align="left" rowspan="1" colspan="1">400</td><td align="left" rowspan="1" colspan="1">360</td></tr><tr><td align="left" rowspan="1" colspan="1">Oscillation width (&#x000b0;)</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Space group</td><td align="left" rowspan="1" colspan="1">P1</td><td align="left" rowspan="1" colspan="1">P1</td><td align="left" rowspan="1" colspan="1">P1</td><td align="left" rowspan="1" colspan="1">P1</td><td align="left" rowspan="1" colspan="1">P1</td></tr><tr><td align="left" rowspan="1" colspan="1">Unit cell parameters&#x02003;<italic>a</italic> (&#x000c5;)&#x02003;<italic>b</italic> (&#x000c5;)&#x02003;<italic>c</italic> (&#x000c5;)</td><td align="left" rowspan="1" colspan="1"><italic>a</italic>&#x0200a;&#x0003d;&#x0200a;79.89<italic>b</italic>&#x0200a;&#x0003d;&#x0200a;78.97<italic>c</italic>&#x0200a;&#x0003d;&#x0200a;117.27<italic>&#x003b1;</italic>&#x0200a;&#x0003d;&#x0200a;84.23<italic>&#x003b2;</italic>&#x0200a;&#x0003d;&#x0200a;80.77<italic>&#x003b3;</italic>&#x0200a;&#x0003d;&#x0200a;64.01</td><td align="left" rowspan="1" colspan="1"><italic>a</italic>&#x0200a;&#x0003d;&#x0200a;81.72<italic>b</italic>&#x0200a;&#x0003d;&#x0200a;82.85<italic>c</italic>&#x0200a;&#x0003d;&#x0200a;114.39<italic>&#x003b1;</italic>&#x0200a;&#x0003d;&#x0200a;102.58<italic>&#x003b2;</italic>&#x0200a;&#x0003d;&#x0200a;92.30<italic>&#x003b3;</italic>&#x0200a;&#x0003d;&#x0200a;106.26</td><td align="left" rowspan="1" colspan="1"><italic>a</italic>&#x0200a;&#x0003d;&#x0200a;81.28<italic>b</italic>&#x0200a;&#x0003d;&#x0200a;82.91<italic>c</italic>&#x0200a;&#x0003d;&#x0200a;114.69<italic>&#x003b1;</italic>&#x0200a;&#x0003d;&#x0200a;103.01<italic>&#x003b2;</italic>&#x0200a;&#x0003d;&#x0200a;91.78<italic>&#x003b3;</italic>&#x0200a;&#x0003d;&#x0200a;106.05</td><td align="left" rowspan="1" colspan="1"><italic>a</italic>&#x0200a;&#x0003d;&#x0200a;78.33<italic>b</italic>&#x0200a;&#x0003d;&#x0200a;79.27<italic>c</italic>&#x0200a;&#x0003d;&#x0200a;117.04<italic>&#x003b1;</italic>&#x0200a;&#x0003d;&#x0200a;80.51<italic>&#x003b2;</italic>&#x0200a;&#x0003d;&#x0200a;83.84<italic>&#x003b3;</italic>&#x0200a;&#x0003d;&#x0200a;64.33</td><td align="left" rowspan="1" colspan="1"><italic>a</italic>&#x0200a;&#x0003d;&#x0200a;81.73<italic>b</italic>&#x0200a;&#x0003d;&#x0200a;82.80<italic>c</italic>&#x0200a;&#x0003d;&#x0200a;115.11<italic>&#x003b1;</italic>&#x0200a;&#x0003d;&#x0200a;102.77<italic>&#x003b2;</italic>&#x0200a;&#x0003d;&#x0200a;91.72<italic>&#x003b3;</italic>&#x0200a;&#x0003d;&#x0200a;106.71</td></tr><tr><td align="left" rowspan="1" colspan="1">Resolution range (&#x000c5;)</td><td align="left" rowspan="1" colspan="1">20.0&#x02013;2.0 (2.07&#x02013;2.0)</td><td align="left" rowspan="1" colspan="1">50&#x02013;2.9 (3.0&#x02013;2.9)</td><td align="left" rowspan="1" colspan="1">50.0&#x02013;2.3 (2.38&#x02013;2.3)</td><td align="left" rowspan="1" colspan="1">50.0&#x02013;2.5 (2.54&#x02013;2.5)</td><td align="left" rowspan="1" colspan="1">50.0&#x02013;3.5 (3.65&#x02013;3.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Completeness (&#x00025;)</td><td align="left" rowspan="1" colspan="1">67.9 (10.7)</td><td align="left" rowspan="1" colspan="1">98.4 (98.7)</td><td align="left" rowspan="1" colspan="1">96.1 (83.4)</td><td align="left" rowspan="1" colspan="1">95.9 (87.5)</td><td align="left" rowspan="1" colspan="1">99.1 (99.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Total measured reflections</td><td align="left" rowspan="1" colspan="1">446903 (6760)</td><td align="left" rowspan="1" colspan="1">430591 (38483)</td><td align="left" rowspan="1" colspan="1">310849 (26427)</td><td align="left" rowspan="1" colspan="1">177674 (7457)</td><td align="left" rowspan="1" colspan="1">130965 (6864)</td></tr><tr><td align="left" rowspan="1" colspan="1">Unique reflections</td><td align="left" rowspan="1" colspan="1">116494 (1827)</td><td align="left" rowspan="1" colspan="1">85254 (8366)</td><td align="left" rowspan="1" colspan="1">121309 (10571)</td><td align="left" rowspan="1" colspan="1">86368 (3925)</td><td align="left" rowspan="1" colspan="1">34434 (1760)</td></tr><tr><td align="left" rowspan="1" colspan="1">Redundancy</td><td align="left" rowspan="1" colspan="1">3.8 (3.7)</td><td align="left" rowspan="1" colspan="1">5.1 (4.6)</td><td align="left" rowspan="1" colspan="1">2.6 (2.5)</td><td align="left" rowspan="1" colspan="1">2.1 (1.9)</td><td align="left" rowspan="1" colspan="1">3.8 (3.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Rsym (&#x00025;)</td><td align="left" rowspan="1" colspan="1">0.046 (0.175)</td><td align="left" rowspan="1" colspan="1">0.098 (0.338)</td><td align="left" rowspan="1" colspan="1">0.036 (0.391)</td><td align="left" rowspan="1" colspan="1">0.065 (0.254)</td><td align="left" rowspan="1" colspan="1">0.095 (0.294)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean I/&#x003c3; (I)</td><td align="left" rowspan="1" colspan="1">46.47 (10.04)</td><td align="left" rowspan="1" colspan="1">22.05 (4.54)</td><td align="left" rowspan="1" colspan="1">24 (1.75)</td><td align="left" rowspan="1" colspan="1">26.90 (2.57)</td><td align="left" rowspan="1" colspan="1">23.07 (6.33)</td></tr><tr><td colspan="6" align="left" rowspan="1">Refinement</td></tr><tr><td align="left" rowspan="1" colspan="1">Resolution limits (&#x000c5;)</td><td align="left" rowspan="1" colspan="1">19.86&#x02013;2.00</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">35.4&#x02013;2.5</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Reflections used</td><td align="left" rowspan="1" colspan="1">110656</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">86282</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Number of refined atoms</td><td align="left" rowspan="1" colspan="1">20628</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">19782</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Rwork (Rfree, &#x00025;)</td><td align="left" rowspan="1" colspan="1">20.30 (25.14)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">22.06 (26.37)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Overall figure of merit</td><td align="left" rowspan="1" colspan="1">0.824</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.795</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Overall B<sub>Wilson</sub> (&#x000c5;<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">21.6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">36.37</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Protein atoms</td><td align="left" rowspan="1" colspan="1">18738</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">18722</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ligand atoms</td><td align="left" rowspan="1" colspan="1">1 Mg</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4 Man<sub>3</sub>-GlcNAc thiazoline</td><td align="left" rowspan="1" colspan="1">4 GlcNAc-Asn</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2 Glycerols</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4 Ca</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1 PO<sub>4</sub></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Solvent atoms</td><td align="left" rowspan="1" colspan="1">1875</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">872</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Bond RMSD lengths (&#x000c5;)/angles (&#x000b0;)</td><td align="left" rowspan="1" colspan="1">0.007/1.027</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.024/1.573</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean B value (&#x000c5;<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">22.04</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">36.84</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">All-atom clash score</td><td align="left" rowspan="1" colspan="1">10.37</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">16.19</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ramachandran favored/allowed/outliers (&#x00025;)</td><td align="left" rowspan="1" colspan="1">97.05/2.86/0.09</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">96.96/3.04/0.00</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="nt103"><p>The numbers in parentheses represent values for the highest resolution shell.</p></fn><fn id="nt104"><label>a</label><p><italic>R</italic><sub>sym</sub>&#x0200a;&#x0003d;&#x0200a;&#x003a3;|<italic>I</italic><sub>i</sub>&#x02212;&#x02329;<italic>I</italic>&#x0232a;|/&#x003a3;<italic>I</italic> where <italic>I</italic><sub>i</sub> is the intensity of the <italic>i</italic>th observation and &#x02329;<italic>I</italic>&#x0232a; is the mean intensity of the reflections.</p></fn><fn id="nt105"><label>b</label><p><italic>R</italic><sub>work</sub>&#x0200a;&#x0003d;&#x0200a;&#x003a3;||<italic>F</italic><sub>obs</sub>|&#x02212;|<italic>F</italic><sub>calc</sub>||/&#x003a3;|<italic>F</italic><sub>obs</sub>| where <italic>F</italic><sub>calc</sub> and <italic>F</italic><sub>obs</sub> are the calculated and observed structure factor amplitude, respectively.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4c"><title>Structure determination and refinement</title><p>ShelxD <xref ref-type="bibr" rid="pone.0004658-Sheldrick1">&#x0005b;28&#x0005d;</xref> was used to locate 36 out of 44 selenium sites. The initial phasing was carried out using Oasis <xref ref-type="bibr" rid="pone.0004658-He1">&#x0005b;29&#x0005d;</xref> and Solve/Resolve <xref ref-type="bibr" rid="pone.0004658-Terwilliger1">&#x0005b;30&#x0005d;</xref> using the 2.9 &#x000c5; Se-SAD data. The experimental phases were transferred and extend to a 2.3 &#x000c5; non-methylated native data set using DMmulti's 8-fold averaging feature between two crystals <xref ref-type="bibr" rid="pone.0004658-Cowtan1">&#x0005b;31&#x0005d;</xref>. The Autobuild feature in Phenix <xref ref-type="bibr" rid="pone.0004658-Adams1">&#x0005b;32&#x0005d;</xref> was able to automatically trace 70&#x00025; of the residues using the non-methylated native data. The model was manually improved using program Coot <xref ref-type="bibr" rid="pone.0004658-Emsley1">&#x0005b;33&#x0005d;</xref> to 80&#x00025; completion before it was used as a MR model to be replaced into the 2.0 &#x000c5; methylated native data set. The model was further improved after several cycles of Arp/Warp <xref ref-type="bibr" rid="pone.0004658-Perrakis1">&#x0005b;34&#x0005d;</xref> water addition combined with manual building. In order to avoid the NCS correlation artifact during the refinement, the thin-shell technique <xref ref-type="bibr" rid="pone.0004658-Kleywegt1">&#x0005b;35&#x0005d;</xref> was used in picking 5&#x00025; of the reflections as test set for Rfree calculation. The NCS restraints were imposed at all stages of refinement. The refinement was carried out with CNS' simulated annealing <xref ref-type="bibr" rid="pone.0004658-Brunger1">&#x0005b;36&#x0005d;</xref> and Refmac <xref ref-type="bibr" rid="pone.0004658-Murshudov1">&#x0005b;37&#x0005d;</xref> alternately using the 2.0 &#x000c5; methylated native dataset and resulted in Rwork value of 20.30&#x00025; and Rfree value of 25.14&#x00025; (<xref ref-type="table" rid="pone-0004658-t002">Table 2</xref>). It is worthy to point out that the refinement converged better (lower Rfree and better stereo chemistry) when CNS and Refmac were used alternately than when the refinement was carried out using only one of the refinement programs. It is quite likely that the combined use of the two programs overcomes the systematic error better than the use of individual programs. The quality of the final model was validated using MOLPROBITY <xref ref-type="bibr" rid="pone.0004658-Davis1">&#x0005b;38&#x0005d;</xref> with 99.87&#x00025; of the residues falling either in the most favored or allowed region of the Ramchandran Plot. Structure of Endo-A in complex with its ligands was determined by molecule replacement using the native structure as a search model. Refinement was carried out using Phenix.refine <xref ref-type="bibr" rid="pone.0004658-Adams1">&#x0005b;32&#x0005d;</xref>.</p><p>In the final refined model, four molecules of Endo-A are assembled into two dimers, presumably due to the crystallographic packing effect. A glycerol molecule, possibly originating from the mother liquor used for crystallization, is seen linking the 2 monomers within a dimer by hydrophobic interactions. The site of dimerization is far away from the active centre. In addition, four Ca<sup>2&#x0002b;</sup>, one ion each of Mg<sup>2&#x0002b;</sup> and PO<sub>4</sub><sup>&#x02212;</sup> are seen in the final model. Electron density for most of the residues from 2&#x02013;615 was visible for Chains A and B, while most of the amino acids from 3&#x02013;615 of Chains C and D could be identified in the crystal structure. Backbone density for 14 amino acids &#x02013; 525:529, 553:555 and 589:594 from China A, 13 amino acids &#x02013; 525:526, 566:568 and 587:594 from Chain B, 13 amino acids &#x02013; 525:526, 542:543, 553:554, 569, and 588:593 from Chain C, and 23 amino acids &#x02013; 527:528, 543:545, 553:555, 567:569 and 584:595 from Chain D could not be traced.</p></sec><sec id="s4d"><title>Synthesis of the Man<sub>3</sub>GlcNAc-thiazoline</title><p>The Man<sub>3</sub>GlcNAc-thiazoline inhibitor was synthesized as described previously <xref ref-type="bibr" rid="pone.0004658-Li3">&#x0005b;22&#x0005d;</xref>.</p></sec><sec id="s4e"><title>Site-directed mutagenesis</title><p>Plasmids containing Endo-A N171A, Y205F and Y299F mutants were constructed using the QuikChange Site-Directed Mutagenesis kit (Stratagene). The Endo-A-pET15b construct (described in protein expression and purification) was used a template for the mutagenesis. The primers used for mutagenesis were designed as follows: N171A_F: <named-content content-type="gene">5&#x02032;- GACGGCTGGTTTATTGCCCAAGAAACAGAAGGG-3&#x02032;</named-content> and N171A_R: <named-content content-type="gene">5&#x02032;- CCCTTCTGTTTCTTGGGCAATAAACCAGCCGTC-3&#x02032;</named-content> for mutant N171A; Y205F_F: <named-content content-type="gene">5&#x02032;- GCACATCATGTGGTTTGACTCGATGATTG-3&#x02032;</named-content> and Y205F_R: <named-content content-type="gene">5&#x02032;- CAATCATCGAGTCAAACCACATGATGTGC-3&#x02032;</named-content> for mutant Y205F; Y299F_F: <named-content content-type="gene">5&#x02032;- CATCACTCGGGTTATTCCGTCCAGATTGGGC-3&#x02032;</named-content> and Y299F_R: <named-content content-type="gene">5&#x02032;- GCCCAATCTGGACGGAATAACCCGAGTGATG-3&#x02032;</named-content> for mutant Y299F. The entire length of the genes were sequenced to verify the mutations and to allow elimination of the constructs with unwanted secondary mutations. Expression and purification of mutants were carried out in the same way as for the wild-type enzyme. Homogeneity of each purified enzyme was confirmed by SDS-PAGE and the concentration of each protein was determined using a protein estimation kit (Bio-rad).</p></sec><sec id="s4f"><title>Activity Assays</title><p>The hydrolysis activity of Endo-A and the mutants was assayed using ribonuclease B (Sigma-Aldrich, USA) as the substrate. The reaction mixture was composed of 100 &#x000b5;g of ribonuclease B and suitably diluted enzymes in an acetate buffer (50 mM, pH 6.0, total volume: 100 &#x000b5;l). After incubation for 5 min at 37&#x000b0;C, the reaction was terminated by the addition of 20 &#x000b5;l of 10&#x00025; trichloroacetic acid. 20 &#x000b5;l of the reaction mixture was analyzed directly by high performance liquid chromatography (HPLC) (Shimadzu, Japan) using a reversed-phase column (Supelco Discovery BIO wide pore C18, 15 cm&#x000d7;4.6 mm). The column was eluted by a gradient of solvent A (water, 0.1&#x00025; trifluoroacetic acid) and solvent B (acetonitrile, 0.1&#x00025; trifluoroacetic acid). The gradient ran from 25&#x00025; B to 30&#x00025; B over 30 min with a flow rate of 0.5 ml/min. Ribonuclease B and the hydrolysis product, deglycosylated Ribonuclease B, were separated and detected by UV-photometry at 254 nm.</p><p>Transglycosylation activity was measured according to the method described previously <xref ref-type="bibr" rid="pone.0004658-Hauser1">&#x0005b;25&#x0005d;</xref>. Briefly, the 50 &#x000b5;l reaction mixture was composed of 1 mM <italic>N</italic>-glycan Man<sub>9</sub>GlcNAc<sub>2</sub>Asn, 2.5 mM 4MU-GlcNAc, 12&#x00025; dimethyl sulfoxide, 50 mU of chitinase from <italic>S. griseus</italic>, 0.25 &#x000b5;g enzymes and 50 &#x000b5;l acetate buffer (50 mM, pH 6.0). The reaction was incubated at 37&#x000b0;C. Aliquots (5 &#x000b5;l) were taken at pre-determined time and added to 200 &#x000b5;l glycine buffer (150 mM, pH 10.5) in a Griener 96-well micro titer plate to quench the reaction. Fluorescence was measured on a micro plate reader (Flex Station 3, Molecular Devices, USA) (excitation, 355 nm; emission, 460 nm).</p></sec><sec id="s4g"><title>Accession numbers</title><p>Coordinates and structure factors for the native and binary complex of Endo-A with Man3GlcNAc-thiazoline have been deposited in the Protein Data Bank (PDB) under the accession code 3FHA and 3FHQ, respectively. The binary complex of Endo-A with GlcNAc-Asn is in the process of being submitted to the PDB.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0004658.s001"><label>Text S1</label><caption><p>Domain 2 and 3 of Endo-A</p><p>(0.02 MB DOC)</p></caption><media xlink:href="pone.0004658.s001.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0004658.s002"><label>Figure S1</label><caption><p>Cartoon representation of CBM36, PDB code 1UX7 (panel A), and Domain 2 of Endo-A (panel B). Residues 364&#x02013;385 form secondary structural elements of Domain 3 (Domain 2 and 3 of Endo-A are interdigitated).</p><p>(0.28 MB PPT)</p></caption><media xlink:href="pone.0004658.s002.ppt" mimetype="application" mime-subtype="vnd.ms-powerpoint"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0004658.s003"><label>Figure S2</label><caption><p>Cartoon representation of the Fibronectin III domain of Integrin &#x003b1;6&#x003b2;4, PDB code 1QG3 (panel A), and Domain 3 of Endo-A (panel B). Electron density for residues 353&#x02013;355 and 589&#x02013;594 was missing.</p><p>(0.26 MB PPT)</p></caption><media xlink:href="pone.0004658.s003.ppt" mimetype="application" mime-subtype="vnd.ms-powerpoint"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0004658.s004"><label>Figure S3</label><caption><p>N171 is seen hydrogen bonded to the nitrogen atom of thiazoline. This interaction is critical for the correct orientation of the C2 acetamido group and helps stabilize the transition states. Amino acids and the Man3GlcNAc-thiazoline are shown as sticks.</p><p>(1.61 MB PPT)</p></caption><media xlink:href="pone.0004658.s004.ppt" mimetype="application" mime-subtype="vnd.ms-powerpoint"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0004658.s005"><label>Figure S4</label><caption><p>Mutagenesis of Y299 to a Phe increases transglycosylation activity by 3 fold. Y299 is seen hydrogen bonded to GlcNAc-Asn. A Y299F mutation abolishes this hydrogen bond resulting in faster product release. Amino acids and the GlcNAc-thiazoline are represented as sticks.</p><p>(0.58 MB PPT)</p></caption><media xlink:href="pone.0004658.s005.ppt" mimetype="application" mime-subtype="vnd.ms-powerpoint"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>pGEX-2T/Endo-A plasmid was a kind gift from Prof. Kaoru Takegawa. The authors thank Tao Zhang and Lijie Wu from Prof. Haifu Fan's group at the Institute of Physics, Chinese Academy of Sciences for the access to the beta version of Oasis phasing program. Crystallographic data were collected at the 19-ID and 19-BM beamlines of APS, Chicago, supported by the U. S. Department of Energy under contract number W-31-109-Eng-38.</p></ack><ref-list><title>References</title><ref id="pone.0004658-Suzuki1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Lennarz</surname><given-names>WJ</given-names></name></person-group><year>1998</year><article-title>Complex, two-way traffic of molecules across the membrane of the endoplasmic reticulum.</article-title><source>J Biol Chem</source><volume>273</volume><fpage>10083</fpage><lpage>10086</lpage><pub-id pub-id-type="pmid">9553052</pub-id></citation></ref><ref id="pone.0004658-Takegawa1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takegawa</surname><given-names>K</given-names></name><name><surname>Nakoshi</surname><given-names>M</given-names></name><name><surname>Iwahara</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Tochikura</surname><given-names>T</given-names></name></person-group><year>1989</year><article-title>Induction and purification of endo-beta -N-acetylglucosaminidase from Arthrobacter protophormiae grown in ovalbumin.</article-title><source>Appl Environ Microbiol</source><volume>55</volume><fpage>3107</fpage><lpage>3112</lpage><pub-id pub-id-type="pmid">16348072</pub-id></citation></ref><ref id="pone.0004658-Bourgerie1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bourgerie</surname><given-names>S</given-names></name><name><surname>Karamanos</surname><given-names>Y</given-names></name><name><surname>Grard</surname><given-names>T</given-names></name><name><surname>Julien</surname><given-names>R</given-names></name></person-group><year>1994</year><article-title>Purification and characterization of an endo-N-acetyl-beta -D-glucosaminidase from the culture medium of Stigmatella aurantiaca DW4.</article-title><source>J Bacteriol</source><volume>176</volume><fpage>6170</fpage><lpage>6174</lpage><pub-id pub-id-type="pmid">7928985</pub-id></citation></ref><ref id="pone.0004658-Fujita1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>K</given-names></name><name><surname>Takami</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Takegawa</surname><given-names>K</given-names></name></person-group><year>2004</year><article-title>Characterization of endo-beta -N-acetylglucosaminidase from alkaliphilic Bacillus halodurans C-125.</article-title><source>Biosci, Biotechnol, Biochem</source><volume>68</volume><fpage>1059</fpage><lpage>1066</lpage><pub-id pub-id-type="pmid">15170110</pub-id></citation></ref><ref id="pone.0004658-Kadowaki1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kadowaki</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Fujisaki</surname><given-names>M</given-names></name><name><surname>Kumagai</surname><given-names>H</given-names></name><name><surname>Tochikura</surname><given-names>T</given-names></name></person-group><year>1988</year><article-title>A novel endo-beta -N-acetylglucosaminidase acting on complex oligosaccharides of glycoproteins in a fungus.</article-title><source>Agric Biol Chem</source><volume>52</volume><fpage>2387</fpage><lpage>2389</lpage></citation></ref><ref id="pone.0004658-Kadowaki2"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kadowaki</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Fujisaki</surname><given-names>M</given-names></name><name><surname>Izumi</surname><given-names>K</given-names></name><name><surname>Tochikura</surname><given-names>T</given-names></name><etal/></person-group><year>1990</year><article-title>Purification and characterization of a novel fungal endo-beta -N-acetylglucosaminidase acting on complex oligosaccharides of glycoproteins.</article-title><source>Agric Biol Chem</source><volume>54</volume><fpage>97</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">1368528</pub-id></citation></ref><ref id="pone.0004658-Li1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>SC</given-names></name><name><surname>Asakawa</surname><given-names>M</given-names></name><name><surname>Hirabayashi</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><year>1981</year><article-title>Isolation of two endo-beta-N-acetylglucosaminidases from fig latex.</article-title><source>Biochim Biophys Acta</source><volume>660</volume><fpage>278</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">6793075</pub-id></citation></ref><ref id="pone.0004658-Kimura1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>Y</given-names></name><name><surname>Matsuo</surname><given-names>S</given-names></name><name><surname>Tsurusaki</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Hara-Nishimura</surname><given-names>I</given-names></name><etal/></person-group><year>2002</year><article-title>Subcellular localization of endo-beta-N-acetylglucosaminidase and high-mannose type free N-glycans in plant cell.</article-title><source>Biochim Biophys Acta</source><volume>1570</volume><fpage>38</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">11960687</pub-id></citation></ref><ref id="pone.0004658-Ito1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Ishida</surname><given-names>K</given-names></name><name><surname>Minamiura</surname><given-names>N</given-names></name></person-group><year>1993</year><article-title>Human salivary endo-beta -N-acetylglucosaminidase HS specific for complex type sugar chains of glycoproteins.</article-title><source>J Biol Chem</source><volume>268</volume><fpage>16074</fpage><lpage>16081</lpage><pub-id pub-id-type="pmid">8340428</pub-id></citation></ref><ref id="pone.0004658-Suzuki2"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Yano</surname><given-names>K</given-names></name><name><surname>Sugimoto</surname><given-names>S</given-names></name><name><surname>Kitajima</surname><given-names>K</given-names></name><name><surname>Lennarz</surname><given-names>WJ</given-names></name><etal/></person-group><year>2002</year><article-title>Endo-beta -N-acetylglucosaminidase, an enzyme involved in processing of free oligosaccharides in the cytosol.</article-title><source>Proc Natl Acad Sci U S A</source><volume>99</volume><fpage>9691</fpage><lpage>9696</lpage><pub-id pub-id-type="pmid">12114544</pub-id></citation></ref><ref id="pone.0004658-Fan1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>J-Q</given-names></name><name><surname>Takegawa</surname><given-names>K</given-names></name><name><surname>Iwahara</surname><given-names>S</given-names></name><name><surname>Kondo</surname><given-names>A</given-names></name><name><surname>Kato</surname><given-names>I</given-names></name><etal/></person-group><year>1995</year><article-title>Enhanced transglycosylation activity of Arthrobacter protophormiae endo-beta -N-acetylglucosaminidase in media containing organic solvents.</article-title><source>J Biol Chem</source><volume>270</volume><fpage>17723</fpage><lpage>17729</lpage><pub-id pub-id-type="pmid">7629071</pub-id></citation></ref><ref id="pone.0004658-Yamamoto1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Kadowaki</surname><given-names>S</given-names></name><name><surname>Fujisaki</surname><given-names>M</given-names></name><name><surname>Kumagai</surname><given-names>H</given-names></name><name><surname>Tochikura</surname><given-names>T</given-names></name></person-group><year>1994</year><article-title>Novel specificities of Mucor hiemalis endo-beta -N-acetylglucosaminidase acting on complex asparagine-linked oligosaccharides.</article-title><source>Biosci, Biotechnol, Biochem</source><volume>58</volume><fpage>72</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">7509658</pub-id></citation></ref><ref id="pone.0004658-Wang1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L-X</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Ni</surname><given-names>J</given-names></name></person-group><year>2004</year><article-title>Synthesis of bioactive glycopeptides through endoglycosidase-catalyzed transglycosylation.</article-title><source>ACS Symp Ser</source><volume>873</volume><fpage>73</fpage><lpage>92</lpage></citation></ref><ref id="pone.0004658-Wang2"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L-X</given-names></name></person-group><year>2006</year><article-title>Toward oligosaccharide- and glycopeptide-based HIV vaccines.</article-title><source>Curr Opin Drug Discovery Dev</source><volume>9</volume><fpage>194</fpage><lpage>206</lpage></citation></ref><ref id="pone.0004658-Wang3"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L-X</given-names></name></person-group><year>2008</year><article-title>Chemoenzymatic synthesis of glycopeptides and glycoproteins through endoglycosidase-catalyzed transglycosylation.</article-title><source>Carbohydr Res</source><volume>343</volume><fpage>1509</fpage><lpage>1522</lpage><pub-id pub-id-type="pmid">18405887</pub-id></citation></ref><ref id="pone.0004658-Li2"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Hauser</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>L-X</given-names></name></person-group><year>2005</year><article-title>Highly Efficient Endoglycosidase-Catalyzed Synthesis of Glycopeptides Using Oligosaccharide Oxazolines as Donor Substrates.</article-title><source>J Am Chem Soc</source><volume>127</volume><fpage>9692</fpage><lpage>9693</lpage><pub-id pub-id-type="pmid">15998066</pub-id></citation></ref><ref id="pone.0004658-Umekawa1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Umekawa</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Fujita</surname><given-names>K</given-names></name><name><surname>Ashida</surname><given-names>H</given-names></name><etal/></person-group><year>2008</year><article-title>Mutants of Mucor hiemalis Endo-beta -N-acetylglucosaminidase Show Enhanced Transglycosylation and Glycosynthase-like Activities.</article-title><source>J Biol Chem</source><volume>283</volume><fpage>4469</fpage><lpage>4479</lpage><pub-id pub-id-type="pmid">18096701</pub-id></citation></ref><ref id="pone.0004658-Ochiai1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ochiai</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>L-X</given-names></name></person-group><year>2008</year><article-title>Expeditious Chemoenzymatic Synthesis of Homogeneous N-Glycoproteins Carrying Defined Oligosaccharide Ligands.</article-title><source>J Am Chem Soc</source><volume>130</volume><fpage>13790</fpage><lpage>13803</lpage><pub-id pub-id-type="pmid">18803385</pub-id></citation></ref><ref id="pone.0004658-Wei1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Strome</surname><given-names>S</given-names></name><etal/></person-group><year>2008</year><article-title>Glycoengineering of Human IgG1-Fc through Combined Yeast Expression and in Vitro Chemoenzymatic Glycosylation.</article-title><source>Biochemistry</source><volume>47</volume><fpage>10294</fpage><lpage>10304</lpage><pub-id pub-id-type="pmid">18771295</pub-id></citation></ref><ref id="pone.0004658-Mackenzie1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname><given-names>LF</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Warren</surname><given-names>RAJ</given-names></name><name><surname>Withers</surname><given-names>SG</given-names></name></person-group><year>1998</year><article-title>Glycosynthases: Mutant Glycosidases for Oligosaccharide Synthesis.</article-title><source>J Am Chem Soc</source><volume>120</volume><fpage>5583</fpage><lpage>5584</lpage></citation></ref><ref id="pone.0004658-Perugino1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perugino</surname><given-names>G</given-names></name><name><surname>Trincone</surname><given-names>A</given-names></name><name><surname>Rossi</surname><given-names>M</given-names></name><name><surname>Moracci</surname><given-names>M</given-names></name></person-group><year>2004</year><article-title>Oligosaccharide synthesis by glycosynthases.</article-title><source>Trends Biotechnol</source><volume>22</volume><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">14690620</pub-id></citation></ref><ref id="pone.0004658-Li3"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Takegawa</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>L-X</given-names></name></person-group><year>2008</year><article-title>Synthesis and inhibitory activity of oligosaccharide thiazolines as a class of mechanism-based inhibitors for endo-beta -N-acetylglucosaminidases.</article-title><source>Bioorg Med Chem</source><volume>16</volume><fpage>4670</fpage><lpage>4675</lpage><pub-id pub-id-type="pmid">18304822</pub-id></citation></ref><ref id="pone.0004658-Waddling1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waddling</surname><given-names>CA</given-names></name><name><surname>Plummer</surname><given-names>TH</given-names><suffix>Jr</suffix></name><name><surname>Tarentino</surname><given-names>AL</given-names></name><name><surname>Van Roey</surname><given-names>P</given-names></name></person-group><year>2000</year><article-title>Structural Basis for the Substrate Specificity of Endo-beta -N-acetylglucosaminidase F3.</article-title><source>Biochemistry</source><volume>39</volume><fpage>7878</fpage><lpage>7885</lpage><pub-id pub-id-type="pmid">10891067</pub-id></citation></ref><ref id="pone.0004658-Fujita2"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>K</given-names></name><name><surname>Takegawa</surname><given-names>K</given-names></name></person-group><year>2001</year><article-title>Tryptophan-216 is essential for the transglycosylation activity of Endo-beta -N-acetylglucosaminidase A.</article-title><source>Biochem Biophys Res Commun</source><volume>283</volume><fpage>680</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">11341779</pub-id></citation></ref><ref id="pone.0004658-Hauser1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hauser</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>L-X</given-names></name></person-group><year>2005</year><article-title>A novel fluorescence-based assay for the transglycosylation activity of endo-beta -N-acetylglucosaminidases.</article-title><source>Biochem Biophys Res Commun</source><volume>328</volume><fpage>580</fpage><lpage>585</lpage><pub-id pub-id-type="pmid">15694387</pub-id></citation></ref><ref id="pone.0004658-Shaw1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>N</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Tempel</surname><given-names>W</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Ng</surname><given-names>J</given-names></name><etal/></person-group><year>2007</year><article-title>(NZ)CH&#x02026;O contacts assist crystallization of a ParB-like nuclease.</article-title><source>BMC Struct Biol</source><volume>7</volume><fpage>46</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">17617922</pub-id></citation></ref><ref id="pone.0004658-Otwinowski1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Otwinowski</surname><given-names>Z</given-names></name><name><surname>Minor</surname><given-names>W</given-names></name></person-group><year>1997</year><article-title>Processing of x-ray diffraction data collected in oscillation mode.</article-title><source>Methods Enzymol</source><volume>276</volume><fpage>307</fpage><lpage>326</lpage></citation></ref><ref id="pone.0004658-Sheldrick1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheldrick</surname><given-names>GM</given-names></name></person-group><year>2008</year><article-title>A short history of SHELX.</article-title><source>Acta Crystallogr, Sect A: Found Crystallogr</source><volume>A64</volume><fpage>112</fpage><lpage>122</lpage></citation></ref><ref id="pone.0004658-He1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>D-Q</given-names></name><name><surname>Gu</surname><given-names>Y-X</given-names></name><name><surname>Lin</surname><given-names>Z-J</given-names></name><name><surname>Zheng</surname><given-names>C-D</given-names></name><etal/></person-group><year>2007</year><article-title>OASIS and molecular-replacement model completion.</article-title><source>Acta Crystallogr, Sect D: Biol Crystallogr</source><volume>D63</volume><fpage>793</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">17582170</pub-id></citation></ref><ref id="pone.0004658-Terwilliger1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Terwilliger</surname><given-names>TC</given-names></name><name><surname>Berendzen</surname><given-names>J</given-names></name></person-group><year>1999</year><article-title>Automated MAD and MIR structure solution.</article-title><source>Acta Crystallogr, Sect D: Biol Crystallogr</source><volume>D55</volume><fpage>849</fpage><lpage>861</lpage><pub-id pub-id-type="pmid">10089316</pub-id></citation></ref><ref id="pone.0004658-Cowtan1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cowtan</surname><given-names>KD</given-names></name><name><surname>Zhang</surname><given-names>KY</given-names></name></person-group><year>1999</year><article-title>Density modification for macromolecular phase improvement.</article-title><source>Prog Biophys Mol Biol</source><volume>72</volume><fpage>245</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">10581970</pub-id></citation></ref><ref id="pone.0004658-Adams1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Hung</surname><given-names>LW</given-names></name><name><surname>Ioerger</surname><given-names>TR</given-names></name><name><surname>McCoy</surname><given-names>AJ</given-names></name><etal/></person-group><year>2002</year><article-title>PHENIX: building new software for automated crystallographic structure determination.</article-title><source>Acta Crystallogr, Sect D: Biol Crystallogr</source><volume>D58</volume><fpage>1948</fpage><lpage>1954</lpage><pub-id pub-id-type="pmid">12393927</pub-id></citation></ref><ref id="pone.0004658-Emsley1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><year>2004</year><article-title>Coot: model-building tools for molecular graphics.</article-title><source>Acta Crystallogr, Sect D: Biol Crystallogr</source><volume>D60</volume><fpage>2126</fpage><lpage>2132</lpage><pub-id pub-id-type="pmid">15572765</pub-id></citation></ref><ref id="pone.0004658-Perrakis1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perrakis</surname><given-names>A</given-names></name><name><surname>Morris</surname><given-names>R</given-names></name><name><surname>Lamzin</surname><given-names>VS</given-names></name></person-group><year>1999</year><article-title>Automated protein model building combined with iterative structure refinement.</article-title><source>Nat Struct Biol</source><volume>6</volume><fpage>458</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">10331874</pub-id></citation></ref><ref id="pone.0004658-Kleywegt1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kleywegt</surname><given-names>GJ</given-names></name><name><surname>Jones</surname><given-names>TA</given-names></name></person-group><year>1996</year><article-title>xdlMAPMAN and xdlDATAMAN - programs for reformatting, analysis and manipulation of biomacromolecular electron-density maps and reflection data sets.</article-title><source>Acta Crystallogr, Sect D: Biol Crystallogr</source><volume>D52</volume><fpage>826</fpage><lpage>828</lpage><pub-id pub-id-type="pmid">15299647</pub-id></citation></ref><ref id="pone.0004658-Brunger1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brunger</surname><given-names>AT</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Clore</surname><given-names>GM</given-names></name><name><surname>DeLano</surname><given-names>WL</given-names></name><name><surname>Gros</surname><given-names>P</given-names></name><etal/></person-group><year>1998</year><article-title>Crystallography&#x00026;NMR System: a new software suite for macromolecular structure determination.</article-title><source>Acta Crystallogr, Sect D: Biol Crystallogr</source><volume>D54</volume><fpage>905</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">9757107</pub-id></citation></ref><ref id="pone.0004658-Murshudov1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murshudov</surname><given-names>GN</given-names></name><name><surname>Vagin</surname><given-names>AA</given-names></name><name><surname>Dodson</surname><given-names>EJ</given-names></name></person-group><year>1997</year><article-title>Refinement of macromolecular structures by the maximum-likelihood method.</article-title><source>Acta Crystallogr, Sect D: Biol Crystallogr</source><volume>D53</volume><fpage>240</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">15299926</pub-id></citation></ref><ref id="pone.0004658-Davis1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>IW</given-names></name><name><surname>Murray</surname><given-names>LW</given-names></name><name><surname>Richardson</surname><given-names>JS</given-names></name><name><surname>Richardson</surname><given-names>DC</given-names></name></person-group><year>2004</year><article-title>MolPROBITY: Structure validation and all-atom contact analysis for nucleic acids and their complexes.</article-title><source>Nucleic Acids Res</source><volume>32</volume><fpage>W615</fpage><lpage>W619</lpage><pub-id pub-id-type="pmid">15215462</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was funded by the National Natural Science Foundation of China (Grants: 20872068, 30721003, 30870483 and 30700123), the Ministry of Health (Grant 2008ZX10404), the Ministry of Science and Technology of China (Grants 2006AA02A316, 2006CB910901, 2006CB910903, 2007CB914803 and 2007CB914403), CAS Research Grant (KSCX2-YW-R-127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>